Intuitive Surgical (ISRG) HR chief trades RSUs and sells shares

Q: How many Intuitive Surgical (ISRG) shares were involved in tax withholding?

A total of 238 shares of Intuitive Surgical common stock were disposed of to satisfy statutory tax withholding. These shares were tied to vesting restricted stock units and were valued at $506.17 per share for the tax-withholding transaction.

Q: What RSU grant did ISRG executive Patricia Wadors receive?

Patricia L. Wadors received a new grant of 3,584 restricted stock units of Intuitive Surgical. Each RSU represents one share of common stock and vests 25% annually , beginning on the first anniversary of the grant date and continuing over four years.

Q: How do Patricia Wadors’ ISRG restricted stock units vest and convert?

Her restricted stock units vest 25% per year over four years , starting one year after grant. On each vesting date, RSUs automatically convert into Intuitive Surgical common stock on a one-for-one basis , with some shares typically withheld to cover tax obligations.

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Intuitive Surgical senior executive Patricia L. Wadors reported mixed equity transactions. She sold 220 shares of common stock in an open-market sale at $499.71 per share under a Rule 10b5-1 trading plan that expires on June 5, 2026. In connection with RSUs vesting, 458 shares were delivered, with 238 shares withheld at $506.17 per share to cover taxes. She also received a new grant of 3,584 restricted stock units that vest 25% annually over four years, each RSU representing one share of common stock upon vesting.

Insider Trade Summary

Net Seller: 220 shares ($109,936)

Net Sell 5 txns

Insider WADORS PATRICIA L

Role SVP Chief Human Resources Offi

Sold 220 shs ($110K)

Type	Security	Shares	Price	Value
Sale	Common Stock	220	$499.71	$110K
Exercise	Restricted Stock Units - 2-26-2025	458	$0.00	--
Grant/Award	Restricted Stock Units - 2-26-2026	3,584	$0.00	--
Exercise	Common Stock	458	$0.00	--
Tax Withholding	Common Stock	238	$506.17	$120K

Holdings After Transaction: Common Stock — 0 shares (Direct); Restricted Stock Units - 2-26-2025 — 1,373 shares (Direct); Restricted Stock Units - 2-26-2026 — 3,584 shares (Direct)

Footnotes (1)

RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 5, 2026. Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.

Form 4 Insider Transactions: What Each Field Means →

02/27/2026 - 06:43 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WADORS PATRICIA L

(Last)

(First)

(Middle)

1020 KIFER ROAD

(Street)

SUNNYVALE

94086

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
INTUITIVE SURGICAL INC [ ISRG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP Chief Human Resources Offi

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/26/2026		M⁽¹⁾		458	A	$0.0	458	D
Common Stock	02/26/2026		F⁽¹⁾		238	D	$506.17	220	D
Common Stock	02/27/2026		S⁽²⁾		220	D	$499.71	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units - 2-26-2025	$0.0	02/26/2026		M			458	⁽³⁾	⁽³⁾	Common Stock	458	$0.0	1,373	D
Restricted Stock Units - 2-26-2026	$0.0	02/26/2026		A		3,584		⁽³⁾	⁽³⁾	Common Stock	3,584	$0.0	3,584	D

Explanation of Responses:

1. RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

2. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 5, 2026.

3. Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.

	By: Stephanie Lim-Ignacio For: Wadors, Patricia	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider stock sale did ISRG executive Patricia Wadors report?

Patricia L. Wadors reported selling 220 shares of Intuitive Surgical common stock in an open-market transaction at $499.71 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan, which is scheduled to expire on June 5, 2026.

How many Intuitive Surgical (ISRG) shares were involved in tax withholding?

A total of 238 shares of Intuitive Surgical common stock were disposed of to satisfy statutory tax withholding. These shares were tied to vesting restricted stock units and were valued at $506.17 per share for the tax-withholding transaction.

What RSU grant did ISRG executive Patricia Wadors receive?

Patricia L. Wadors received a new grant of 3,584 restricted stock units of Intuitive Surgical. Each RSU represents one share of common stock and vests 25% annually, beginning on the first anniversary of the grant date and continuing over four years.

How do Patricia Wadors’ ISRG restricted stock units vest and convert?

Her restricted stock units vest 25% per year over four years, starting one year after grant. On each vesting date, RSUs automatically convert into Intuitive Surgical common stock on a one-for-one basis, with some shares typically withheld to cover tax obligations.

Was Patricia Wadors’ ISRG stock sale under a 10b5-1 plan?

Yes. The reported sale of 220 Intuitive Surgical shares occurred under a Rule 10b5-1 trading plan. This pre-arranged plan sets predetermined trading instructions and, in this case, is described as expiring on June 5, 2026.

What derivative transactions did ISRG report for Patricia Wadors?

Intuitive Surgical reported RSU-related derivative activity for Patricia Wadors, including the exercise or conversion of 458 RSUs into common stock and a new grant of 3,584 RSUs. These transactions involve no cash purchase price and follow the company’s vesting schedule.